drugset / Trial / NCT05569239
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
RandomizedParallel-groupDouble-blindPrevention
Summary
The present study will evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years.
Timeline
- Start
- 2025-09-08
- Primary completion
- 2026-05-29
- Completion
- 2026-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OVX836 | Vaccine | 480 ug | Intramuscular |